Cargando…

Routine laboratory testing in hemodialysis: how frequently is it needed?

BACKGROUND: Hemodialysis patients are followed by routine laboratory testing. There is uncertainty whether these tests always lead to a change in decision-making. This study aims to discover the number of yearly interventions/changes in prescription based on these tests and depict the group of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Chidiac, Claudia, Chelala, Dania, Nassar, Dany, Beaini, Chadia, Azar, Hiba, Finianos, Serge, Boueri, Celine, Hawi, Jenny, Abdo, Ibrahim, Aoun, Mabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615394/
https://www.ncbi.nlm.nih.gov/pubmed/36303122
http://dx.doi.org/10.1186/s12882-022-02971-9
_version_ 1784820412197109760
author Chidiac, Claudia
Chelala, Dania
Nassar, Dany
Beaini, Chadia
Azar, Hiba
Finianos, Serge
Boueri, Celine
Hawi, Jenny
Abdo, Ibrahim
Aoun, Mabel
author_facet Chidiac, Claudia
Chelala, Dania
Nassar, Dany
Beaini, Chadia
Azar, Hiba
Finianos, Serge
Boueri, Celine
Hawi, Jenny
Abdo, Ibrahim
Aoun, Mabel
author_sort Chidiac, Claudia
collection PubMed
description BACKGROUND: Hemodialysis patients are followed by routine laboratory testing. There is uncertainty whether these tests always lead to a change in decision-making. This study aims to discover the number of yearly interventions/changes in prescription based on these tests and depict the group of patients who would benefit from reduced or increased laboratory blood tests. METHODS: This is a multi-center retrospective study that included patients on hemodialysis for more than one year. Laboratory data collected included yearly average of hemoglobin, urea reduction ratio (URR), serum phosphate, calcium, potassium, parathormone (PTH), ferritin and transferrin saturation (TSAT); changes in prescription of erythropoietin-stimulating agents (ESAs), intravenous (IV) iron, alfacalcidol, phosphate binders and dialysis parameters were retrieved from medical records. A multivariate regression analysis assessed factors associated with high number of interventions. RESULTS: A total of 210 hemodialysis patients were included: 62.4% males, 47.1% diabetics. Their median age was 72 (62,78.5) years. Their laboratory parameters were within KDIGO targets. The median number of yearly interventions was 5 (3,7) for ESAs, 4 (2,6) for IV iron, 1 (0,2.25) for phosphate binders, 0 (0,1) for alfacalcidol. Based on the multivariate analysis, patients with higher ferritin, frequent changes in ESA, more changes in alfacalcidol and higher PTH had higher number of prescription’s changes in ESA, IV iron, phosphate binders and alfacalcidol respectively. CONCLUSION: While maintaining KDIGO targets, therapeutic interventions following routine laboratory testing did not exceed six times yearly for all parameters. This suggests that a reduced testing frequency in hemodialysis patients is possible without any impact on quality of care. A personalized approach remains safe for hemodialysis patients while reducing the cost. This is very relevant in low-resource settings and during economic crises and needs to be evaluated in prospective studies.
format Online
Article
Text
id pubmed-9615394
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96153942022-10-29 Routine laboratory testing in hemodialysis: how frequently is it needed? Chidiac, Claudia Chelala, Dania Nassar, Dany Beaini, Chadia Azar, Hiba Finianos, Serge Boueri, Celine Hawi, Jenny Abdo, Ibrahim Aoun, Mabel BMC Nephrol Research BACKGROUND: Hemodialysis patients are followed by routine laboratory testing. There is uncertainty whether these tests always lead to a change in decision-making. This study aims to discover the number of yearly interventions/changes in prescription based on these tests and depict the group of patients who would benefit from reduced or increased laboratory blood tests. METHODS: This is a multi-center retrospective study that included patients on hemodialysis for more than one year. Laboratory data collected included yearly average of hemoglobin, urea reduction ratio (URR), serum phosphate, calcium, potassium, parathormone (PTH), ferritin and transferrin saturation (TSAT); changes in prescription of erythropoietin-stimulating agents (ESAs), intravenous (IV) iron, alfacalcidol, phosphate binders and dialysis parameters were retrieved from medical records. A multivariate regression analysis assessed factors associated with high number of interventions. RESULTS: A total of 210 hemodialysis patients were included: 62.4% males, 47.1% diabetics. Their median age was 72 (62,78.5) years. Their laboratory parameters were within KDIGO targets. The median number of yearly interventions was 5 (3,7) for ESAs, 4 (2,6) for IV iron, 1 (0,2.25) for phosphate binders, 0 (0,1) for alfacalcidol. Based on the multivariate analysis, patients with higher ferritin, frequent changes in ESA, more changes in alfacalcidol and higher PTH had higher number of prescription’s changes in ESA, IV iron, phosphate binders and alfacalcidol respectively. CONCLUSION: While maintaining KDIGO targets, therapeutic interventions following routine laboratory testing did not exceed six times yearly for all parameters. This suggests that a reduced testing frequency in hemodialysis patients is possible without any impact on quality of care. A personalized approach remains safe for hemodialysis patients while reducing the cost. This is very relevant in low-resource settings and during economic crises and needs to be evaluated in prospective studies. BioMed Central 2022-10-27 /pmc/articles/PMC9615394/ /pubmed/36303122 http://dx.doi.org/10.1186/s12882-022-02971-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chidiac, Claudia
Chelala, Dania
Nassar, Dany
Beaini, Chadia
Azar, Hiba
Finianos, Serge
Boueri, Celine
Hawi, Jenny
Abdo, Ibrahim
Aoun, Mabel
Routine laboratory testing in hemodialysis: how frequently is it needed?
title Routine laboratory testing in hemodialysis: how frequently is it needed?
title_full Routine laboratory testing in hemodialysis: how frequently is it needed?
title_fullStr Routine laboratory testing in hemodialysis: how frequently is it needed?
title_full_unstemmed Routine laboratory testing in hemodialysis: how frequently is it needed?
title_short Routine laboratory testing in hemodialysis: how frequently is it needed?
title_sort routine laboratory testing in hemodialysis: how frequently is it needed?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615394/
https://www.ncbi.nlm.nih.gov/pubmed/36303122
http://dx.doi.org/10.1186/s12882-022-02971-9
work_keys_str_mv AT chidiacclaudia routinelaboratorytestinginhemodialysishowfrequentlyisitneeded
AT chelaladania routinelaboratorytestinginhemodialysishowfrequentlyisitneeded
AT nassardany routinelaboratorytestinginhemodialysishowfrequentlyisitneeded
AT beainichadia routinelaboratorytestinginhemodialysishowfrequentlyisitneeded
AT azarhiba routinelaboratorytestinginhemodialysishowfrequentlyisitneeded
AT finianosserge routinelaboratorytestinginhemodialysishowfrequentlyisitneeded
AT bouericeline routinelaboratorytestinginhemodialysishowfrequentlyisitneeded
AT hawijenny routinelaboratorytestinginhemodialysishowfrequentlyisitneeded
AT abdoibrahim routinelaboratorytestinginhemodialysishowfrequentlyisitneeded
AT aounmabel routinelaboratorytestinginhemodialysishowfrequentlyisitneeded